• Latest Posts

The six most advanced microbiome players aiming for the gut

FDA’s approval of first fecal microbiota product, Rebyota, hailed an ‘enormous step forward’ for the field

Interview 14 Nov 2022

MaaT Pharma: leading the charge in microbiome therapeutics

Startup Creator Launched to Fill Europe’s Microbiome Translational Gap

Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference

Microbiome Therapies Threatened by Covid-19 Restrictions


MaaT Pharma’s Microbiome Cancer Treatment Given €18M Boost

Will US Fecal Transplant Death Impact European Biotech?

Microbiome Companies Unite to Push for EU Regulation Reform

In Depth 22 Jan 2019

No Guts, No Glory: How Microbiome Research is Changing Medicine

Microbiome Therapy Shows Early Promise in Cancer Patients